Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 2
1957 1
1958 1
1959 2
1960 2
1961 1
1962 1
1964 1
1965 4
1966 5
1967 3
1968 3
1969 3
1970 6
1971 8
1972 5
1973 3
1974 7
1975 18
1976 13
1977 8
1978 22
1979 29
1980 18
1981 63
1982 40
1983 45
1984 43
1985 61
1986 52
1987 51
1988 48
1989 49
1990 45
1991 32
1992 58
1993 19
1994 30
1995 31
1996 21
1997 16
1998 27
1999 31
2000 27
2001 36
2002 28
2003 27
2004 17
2005 20
2006 27
2007 16
2008 12
2009 22
2010 21
2011 16
2012 21
2013 20
2014 15
2015 25
2016 14
2017 21
2018 11
2019 14
2020 20
2021 12
2022 14
2023 13
2024 11
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,378 results

Results by year

Filters applied: . Clear all
Page 1
Anthralin/dithranol in dermatology.
Sehgal VN, Verma P, Khurana A. Sehgal VN, et al. Int J Dermatol. 2014 Oct;53(10):e449-60. doi: 10.1111/j.1365-4632.2012.05611.x. Epub 2014 Sep 10. Int J Dermatol. 2014. PMID: 25208745 Review.
Anthralin (1,8-dihydroxy-9anthrone, dithranol) was first synthesized as a derivative of chrysarobin, prepared from the araroba tree in Brazil over a century ago. Drawbacks to the use of anthralin include irritation and discoloration of the skin. This property …
Anthralin (1,8-dihydroxy-9anthrone, dithranol) was first synthesized as a derivative of chrysarobin, prepared from the araroba …
Anthralin: historical and current perspectives.
Ashton RE, Andre P, Lowe NJ, Whitefield M. Ashton RE, et al. J Am Acad Dermatol. 1983 Aug;9(2):173-92. doi: 10.1016/s0190-9622(83)70125-8. J Am Acad Dermatol. 1983. PMID: 6309924 Review.
Anthralin was first used in Germany, and later in the Ingram regimen in Britain, but it has never been popular with American dermatologists. ...The aims of this review are to discuss historical aspects of anthralin and to update its chemistry, pharmacology, and clin …
Anthralin was first used in Germany, and later in the Ingram regimen in Britain, but it has never been popular with American dermatol …
Anthralin.
Shroot B. Shroot B. Dermatologica. 1986;173(6):261-3. doi: 10.1159/000249268. Dermatologica. 1986. PMID: 3817237 No abstract available.
[Anthralin].
Shroot B. Shroot B. Ann Dermatol Venereol. 1987;114(12):1623-30. Ann Dermatol Venereol. 1987. PMID: 3445989 French. No abstract available.
Anthralin therapy for alopecia areata.
Nelson DA, Spielvogel RL. Nelson DA, et al. Int J Dermatol. 1985 Nov;24(9):606-7. doi: 10.1111/j.1365-4362.1985.tb05863.x. Int J Dermatol. 1985. PMID: 3905640 Clinical Trial.
Topical anthralin application producing a brisk irritant contact dermatitis has been reported to have therapeutic benefit in alopecia areata. A pilot clinical study was undertaken to determine whether topical anthralin application in doses low enough to produce only …
Topical anthralin application producing a brisk irritant contact dermatitis has been reported to have therapeutic benefit in alopecia …
Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
Müller K. Müller K. Biochem Pharmacol. 1997 May 9;53(9):1215-21. doi: 10.1016/s0006-2952(96)00732-0. Biochem Pharmacol. 1997. PMID: 9214681 Review.
The biochemical basis for the induction of an inflammatory response in the skin and the antipsoriatic effectiveness are uncertain, although several cellular targets of anthralin action have been identified. Because no single mechanism is operative, the view was taken that …
The biochemical basis for the induction of an inflammatory response in the skin and the antipsoriatic effectiveness are uncertain, although …
Short-contact anthralin therapy.
Yarrow M. Yarrow M. J Am Acad Dermatol. 1991 Apr;24(4):665-6. doi: 10.1016/s0190-9622(08)80180-6. J Am Acad Dermatol. 1991. PMID: 1812844 No abstract available.
Dithranol.
Mahrle G. Mahrle G. Clin Dermatol. 1997 Sep-Oct;15(5):723-37. doi: 10.1016/s0738-081x(97)00019-9. Clin Dermatol. 1997. PMID: 9313971 Review. No abstract available.
Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J, Fehrenbacher B, Brück J, Müller-Hermelink E, Schäfer I, Carevic M, Schittek B, Schaller M, Ghoreschi K, Eberle FC. Holstein J, et al. J Dermatol Sci. 2017 Sep;87(3):236-245. doi: 10.1016/j.jdermsci.2017.06.007. Epub 2017 Jun 15. J Dermatol Sci. 2017. PMID: 28673488
Psoriasis treatment options include modern targeted therapies using anti-cytokine antibodies and traditional non-targeted treatments like anthralin (dithranol). While the mode of action of anti-cytokine antibodies is defined, the effects of topical anthralin …
Psoriasis treatment options include modern targeted therapies using anti-cytokine antibodies and traditional non-targeted treatments like …
[Dithranol].
Melhorn S. Melhorn S. Hautarzt. 2017 May;68(5):421-423. doi: 10.1007/s00105-017-3977-5. Hautarzt. 2017. PMID: 28401270 German. No abstract available.
1,378 results